Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822919) titled 'A Study of AWT020 in Participants With Advanced Solid Tumors' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Anwita Biosciences

Condition: Advanced Cancers (Solid Tumors)

Intervention: Biological: AWT020

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: September 11, 2026

Target Sample Size: 96

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07822919

Disclaimer: Curated by HT Syndication....